Table 2:
Comparison of baseline characteristics among the 3 groups
| CE (n = 110) | LAA (n = 43) | Undetermined Etiology (n = 41) | Pa | Pb | |
|---|---|---|---|---|---|
| Age (yr) | 74 (66–80) | 67 (56–79) | 63 (59–79) | .016 | .016 |
| Male sex (No.) (%) | 52 (47.3%) | 32 (74.4%) | 28 (68.3%) | .003 | .002 |
| Baseline NIHSS score | 14 (10–18) | 10 (5–14) | 14 (9–18) | .002 | .001 |
| Systolic BP (mm Hg) | 150 (133–168) | 154 (138–164) | 144 (129–155) | .172 | .450 |
| Diastolic BP (mm Hg) | 79 (71–94) | 80 (72–93) | 78 (68–89) | .370 | .955 |
| Onset-to-imaging time (min) | 154 (92–225) | 163 (112–230) | 197 (134–262) | .128 | .540 |
| Prior antiplatelet use (No.) (%) | 19 (17.3%) | 6 (14.0%) | 8 (19.5%) | .790 | .618 |
| Risk factors | |||||
| Smoking (No.) (%) | 28 (25.5%) | 21 (48.8%) | 16 (39.0%) | .016 | .005 |
| Hypertension (No.) (%) | 73 (66.4%) | 29 (67.4%) | 23 (56.1%) | .451 | .899 |
| Diabetes mellitus (No.) (%) | 20 (18.2%) | 11 (25.6%) | 5 (12.2%) | .285 | .306 |
| Hyperlipidemia (No.) (%) | 41 (37.3%) | 15 (34.9%) | 17 (41.5%) | .818 | .783 |
| History of stroke/TIA (No.) (%) | 19 (17.3%) | 9 (20.9%) | 4 (9.8%) | .365 | .599 |
| Atrial fibrillation (No.) (%) | 98 (89.1%) | 0 (0.0%) | 11 (26.8%) | <.001 | <.001 |
| MSC sign (No.) (%) | 58 (52.7%) | 4 (9.3%) | 12 (29.3%) | <.001 | <.001 |
Note:—BP indicates blood pressure.
a
Data are expressed as median (Q1–Q3) for continuous variables among the 3 groups.
b
Data are expressed as median (Q1–Q3) for continuous variables between CE and LAA.